Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL. - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Beta test our new site.

(NLM Technical Bulletin)

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.

The recruitment status of this study is unknown because the information has not been verified recently.

Verified October 2005 by Zeneus Pharma.
Recruitment status was Active, not recruiting

Study NCT00244127 Information provided by Zeneus Pharma

First Received on October 24, 2005. Last Updated on October 26, 2005 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Additional conditions recognized in this trial

Aggression
Lymphoma
Lymphoma, Non-Hodgkin

More general conditions related to this trial

Behavioral Symptoms
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type

Additional drug interventions recognized in this trial

Cyclophosphamide
Doxorubicin
Prednisone
Rituximab
Vincristine

Sponsors listed in this trial

Zeneus Pharma

Back to top of Main Content